These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3632098)

  • 1. In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate.
    el-On J; Rubinstein N; Kernbaum S; Schnur LF
    Ann Trop Med Parasitol; 1986 Oct; 80(5):509-17. PubMed ID: 3632098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL
    Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    J Antimicrob Chemother; 1997 Aug; 40(2):287-9. PubMed ID: 9301998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
    Convit J; Castellanos PL; Rondon A; Pinardi ME; Ulrich M; Castes M; Bloom B; Garcia L
    Lancet; 1987 Feb; 1(8530):401-5. PubMed ID: 2880213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM; Marsden PD
    Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-substituted quinoline alkaloids as potential antileishmanial drugs.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A; Bruneton J
    Antimicrob Agents Chemother; 1993 Apr; 37(4):859-63. PubMed ID: 8494383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
    Adinolfi LE; Bonventre PF
    Am J Trop Med Hyg; 1985 Mar; 34(2):270-7. PubMed ID: 3985270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.
    Robledo SM; Valencia AZ; Saravia NG
    J Parasitol; 1999 Apr; 85(2):360-6. PubMed ID: 10219320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
    Gramiccia M; Gradoni L; Orsini S
    Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico.
    Vargas-Gonzalez A; Canto-Lara SB; Damian-Centeno AG; Andrade-Narvaez FJ
    Am J Trop Med Hyg; 1999 Dec; 61(6):960-3. PubMed ID: 10674678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of experimental visceral leishmaniasis in the opossum.
    White MR; Chapman WL; Hanson WL
    J Parasitol; 1989 Feb; 75(1):176-8. PubMed ID: 2918440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
    Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.